Literature DB >> 19373688

Proliferative vitreoretinopathy: pathobiology and therapeutic targets.

Yannek I Leiderman1, Joan W Miller.   

Abstract

The cell biology and molecular mediators of proliferative vitreoretinopathy continue to be elucidated. The purpose of this review is to summarize contemporary findings in the visual and neurosciences relevant to the pathophysiology of proliferative vitreoretinopathy, with an emphasis on the biologic mediators that represent potential therapeutic targets.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19373688     DOI： 10.1080/08820530902800082

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN： 0882-0538            Impact factor:   1.975


  20 in total

Review 1.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

2.  Comparative transcriptomic analysis reveals adriamycin-induced apoptosis via p53 signaling pathway in retinal pigment epithelial cells.

Authors:  Yu-Chen Lin; Ze-Ren Shen; Xiao-Hui Song; Xin Liu; Ke Yao
Journal:  J Zhejiang Univ Sci B       Date:  2018 Dec.       Impact factor: 3.066

3.  Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal detachment with PVR and inferior breaks.

Authors:  Khaled G Abu Eleinen; Ahmed A Mohalhal; Dalia A Ghalwash; Ahmed A Abdel-Kader; Ahmed A Ghalwash; Islam A Mohalhal; Abdussalam M Abdullatif
Journal:  Eye (Lond)       Date:  2018-08-16       Impact factor: 3.775

4.  Expression of IGFBP-6 in a proliferative vitreoretinopathy rat model and its effects on retinal pigment epithelial cell proliferation and migration.

Authors:  Hong-Mei Zhao; Min-Jie Sheng; Jing Yu
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

5.  Deferred laser photocoagulation of relaxing retinotomies under silicone oil tamponade to reduce recurrent macular detachment in severe proliferative vitreoretinopathy.

Authors:  Marc Veckeneer; Kristel Maaijwee; David G Charteris; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-18       Impact factor: 3.117

6.  Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII.

Authors:  Rima Khankan; Noelynn Oliver; Shikun He; Stephen J Ryan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-07       Impact factor: 4.799

Review 7.  Periostin in vitreoretinal diseases.

Authors:  Shigeo Yoshida; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

Review 8.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

9.  Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells.

Authors:  Bing Liu; Jingyuan Song; Haote Han; Zhengping Hu; Na Chen; Jing Cui; Joanne Aiko Matsubara; Jingxiang Zhong; Hetian Lei
Journal:  Lab Invest       Date:  2019-08-22       Impact factor: 5.662

10.  Quinotrierixin inhibits proliferation of human retinal pigment epithelial cells.

Authors:  Chen Chen; Joshua J Wang; Jingming Li; Qiang Yu; Sarah X Zhang
Journal:  Mol Vis       Date:  2013-01-07       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.